Lessons learned from the hGH era

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 10, 2011, Pages 3042-3047

  Allen, David B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT PROTEIN;

BODY HEIGHT; CLINICAL DECISION MAKING; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; OBESITY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; REVIEW; SHORT STATURE; CHEMISTRY; DRUG EFFECT; HYPOPHYSIS; PHYSIOLOGY; SOCIAL BEHAVIOR;

BODY HEIGHT; GROWTH HORMONE; HUMANS; PITUITARY GLAND; RECOMBINANT PROTEINS; SOCIAL BEHAVIOR;

EID: 80053467926     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1739     Document Type: Review

References (38)

1. Cohen S, Cosgrove C 2010 Too tall, too small? The temptation to tinker with a child's height. Lancet 375:454-455
2. Zinn H 1980 The people's history of the United States. New York: Harper Collins Publishers Inc.
3. Gibbs Jr CJ, Joy A, Heffner R, Franko M, Miyazaki M, Asher DM, Parisi JE, Brown PW, Gajdusek DC 1985 Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 313:734-748
4. Hintz RL 1995 The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment. J Clin Endocrinol Metab 80:2298-2301
5. Tauber M, Moulin P, Pienkowski C, Jouret B, Rochiccioli P 1997 Growth hormone retesting and auxological data of 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 82:352-356 (Pubitemid 27068591)
6. Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, Severi F 1999 Growth hormone deficiency of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 84:1324-1328 (Pubitemid 30644394)
7. Guyda HJ 2000 Growth hormone testing and the short child. Pediatr Res 48:579-580
8. Daniels N 1992 Growth hormone therapy for short stature: can we support the treatment enhancement distinction? Growth Genet Horm 8(Suppl 1):46-48
9. Lantos J, Siegler M, Cuttler L 1989 Ethical issues in growth hormone therapy. JAMA 261:1020-1024 (Pubitemid 19054150)
10. Allen DB, Fost NC 1990 Growth hormone for short stature: panacea or Pandora's box? J Pediatr 117:16-21 (Pubitemid 20217488)
11. Moshang Jr T 1991 Growth hormone and normal short children. J Pediatr 118:164-165
12. Buchanan A 2001 Growth hormone: a paradigm of expansive biotechnologies. Endocrinologist 11:78S-82S (Pubitemid 32717762)
13. Wyatt D 2004 Lessons from the National Cooperative Growth Study. Eur J Endocrinol 151:S55-S59 (Pubitemid 39276348)
14. Allen DB 2010 Growth hormone post-marketing surveillance: safety, sales, and the unfinished task ahead. J Clin Endocrinol Metab 95:52-55
15. Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, Lippe B 2005 Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab 90:5247-5253 (Pubitemid 41262282)
16. Savage MO, Burren CP, Rosenfeld RG 2010 A continuum of GHIGF axis defects causing short stature: diagnostic and therapeutic challenges. Clin Endocrinol (Oxf) 72:721-728
17. Sandberg DE, Brook AE, Campos SP 1994 Short stature: a psychosocial burden requiring growth hormone therapy? Pediatrics 94:832-840 (Pubitemid 24359186)
18. Ulph F, Betts P, Mulligan J, Stratford RJ 2004 Personality functioning: the influence of stature. Arch Dis Child 89:17-21 (Pubitemid 38122001)
19. Sandberg DE, Bukowski WM, Fung CM, Noll RB 2004 Height and social adjustment: are extremes a cause for concern and action. Pediatrics 114:744-750 (Pubitemid 41529533)
20. Lee JM, Appugliese D, Coleman SM, Kaciroti N, Corwyn RF, Bradley RH, Sandberg DE, Lumeng JC 2009 Short stature in a population-based cohort: social, emotional, and behavioral functioning. Pediatrics 124:903-910
21. Samaras TT 2009 We are too tall. Public Health Nutr 12:439
22. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J 2004 Effect of GH treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, controlled trial. J Clin Endocrinol Metab 89:3140-3148 (Pubitemid 38960690)
23. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF 2005 Growth hormone treatment to adult height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146:45-53 (Pubitemid 40091730)
24. Elder CJ, Barton JS, Brook CG, Preece MA, Dattani MT, Hindmarsh PC 2008 A randomized study of the effect of two doses of biosynthetic hGH on final height of children with familial short stature. Horm Res 70:89-92
25. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L 2002 Effect of GH therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 156:230-240 (Pubitemid 34205433)
26. Bryant J, Baxter L, Cave CB, Milne R 2007 Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev CD004440
27. van Gool SA, Kamp GA, Odink RJ, De Muinck Keizer-Schrama SM, Delemarre-van de Waal HA, Oostdijk W, Wit JM 2010 High dose hGH treatment limited to the prepubertal period in young children with ISS does not increase adult height. Eur J Endocrinol 162:653-660
28. Lagrou K, Froidecoeur C, Verlinde F, Craen M, De Schepper J, François I, Massa G; Belgian Study Group of Paediatric Endocrinology 2006 Psychosocial functioning, self-perception and body image and their auxological correlates in GH and oestrogen-treated young adult women with Turner syndrome. Horm Res 66:277-284 (Pubitemid 44795911)
29. Visser-van Balen H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G 2007 Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatrica 96:715-719 (Pubitemid 46653171)
30. Office for Human Research Protections (OHRP) 2004 Belmont report. Ethical principles and guidelines for the protection of human subjects of research. U.S. Department of Health and Human Services. http://www.hhs.gov/ohrp/archive/ belmontArchive.html
31. Allen DB 2006 Growth hormone therapy for short stature: is the benefit worth the burden. Pediatrics 118:343-348 (Pubitemid 46071181)
32. Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B 2010 Long-term safety of recombinant growth hormone in children. J Clin Endocrinol Metab 95:167-177
33. Child CJ, Zimmermann AG, Scott RS, Cutler Jr GB, Battelino T, Blum WF; GeNeSIS International Advisory Board 2011 Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research study. J Clin Endocrinol Metab 96:E1025-E1034
34. U.S. Food and Drug Administration 22 December 2010 Alert: recombinant human growth hormone (somatropin): ongoing safety review-possible increased risk of death. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm237969.htm
35. Dreger A 2001 Are children dying for an inch or two? The ethics and dangers of treating children with growth-boosting drugs. Chicago Tribune, March 20, 2011
36. Rosenbloom AL 2011 Pediatric endo-cosmetology and the evolution of growth diagnosis and treatment. J Pediatr 158:187-193
37. Diekema DS 1990 Is taller really better? Growth hormone therapy in short children. Perspect Biol Med 34:109-123 (Pubitemid 20383355)
38. Varness T, Allen DB, Carrel AL, Fost N 2009 Childhood obesity and medical neglect. Pediatrics 123:399-406